Conatus Pharmaceuticals Inc. buy melinda
Start price
02.04.19
/
50%
€10.46
Target price
30.10.19
€19.84
Performance (%)
-79.93%
End price
30.10.19
€2.10
Summary
This prediction ended on 30.10.19 with a price of €2.10. The BUY prediction by melinda for Conatus Pharmaceuticals Inc. performed very badly with a performance of -79.93%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Conatus Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by melinda for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
Secteur Recherche biotechnologique et médicale Agenda 13/04 | 16:00
Buy closed
Stopped prediction by melinda for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.61
11.12.18
11.12.18
€27.06
09.01.19
09.01.19
29.63%
09.01.19
09.01.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€35.45
06.12.17
06.12.17
€36.98
08.12.17
08.12.17
4.83%
08.12.17
08.12.17
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.48
06.02.17
06.02.17
€49.61
30.03.17
30.03.17
5.62%
30.03.17
30.03.17